Stem Cell Research (Apr 2022)

Generation of a patient-derived induced pluripotent cell line (SCTCi016-A) carrying a homozygous variant in RPE65

  • Irene Vázquez-Domínguez,
  • Michael Kwint,
  • Hester Y Kroes,
  • Silvia Albert,
  • Luke O'Gorman,
  • Christian Gilissen,
  • Frans P.M. Cremers,
  • Rob W.J. Collin,
  • Susanne Roosing,
  • Alejandro Garanto

Journal volume & issue
Vol. 60
p. 102689

Abstract

Read online

Leber congenital amaurosis (LCA) can be caused by mutations in more than 20 different genes. One of these, RPE65, encodes a protein essential for the visual cycle that is expressed in retinal pigment epithelium cells. In this work, we describe the generation and characterization of the human iPSC line SCTCi16-A. This hiPSC line was generated from peripheral blood mononuclear cells (PBMCs) from a patient affected with LCA caused by the homozygous c.11+5G>A variant in the RPE65 gene. Reprograming was conducted using episomal vectors containing OCT3/4, SOX2, KLF4, L-MYC, and LIN28.